全文获取类型
收费全文 | 630篇 |
免费 | 51篇 |
国内免费 | 2篇 |
学科分类
医药卫生 | 683篇 |
出版年
2024年 | 1篇 |
2023年 | 4篇 |
2022年 | 10篇 |
2021年 | 43篇 |
2020年 | 24篇 |
2019年 | 34篇 |
2018年 | 33篇 |
2017年 | 21篇 |
2016年 | 25篇 |
2015年 | 29篇 |
2014年 | 40篇 |
2013年 | 49篇 |
2012年 | 73篇 |
2011年 | 62篇 |
2010年 | 32篇 |
2009年 | 23篇 |
2008年 | 29篇 |
2007年 | 30篇 |
2006年 | 26篇 |
2005年 | 26篇 |
2004年 | 13篇 |
2003年 | 18篇 |
2002年 | 10篇 |
2000年 | 1篇 |
1999年 | 2篇 |
1998年 | 1篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 4篇 |
1992年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有683条查询结果,搜索用时 998 毫秒
21.
Einollahi B Hajarizadeh B Bakhtiari S Lesanpezeshki M Khatami MR Nourbala MH Pourfarziani V Alavian SM 《Journal of gastroenterology and hepatology》2003,18(7):836-840
BACKGROUND: Hepatitis C virus infection (HCV) is a main health problem in end-stage renal disease (ESRD) patients. The effect of pretransplant HCV infection on survival among ESRD patients who have undergone renal transplantation is controversial. We report the results of a large monocenter study that evaluated the effect of hepatitis C on the patient, and on graft survival in renal-transplanted patients who received living donated allograft. METHODS: A historical cohort study, we investigated all 1006 patients who received a living kidney transplant at Baghiatollah Medical Center in Tehran, Iran, between March 1995 and October 2001 (up to 85 months follow up). Patients' sera had been routinely assayed for anti-HCV antibodies and hepatitis B surface antigen (HBsAg) at the time of transplantation. The HBsAg-positive patients were excluded from the survival analysis. Survivals were examined using Kaplan-Meier analysis and compared using the log-rank test. Multivariate analysis was performed using Cox's model. RESULTS: Forty-five patients (4.5%) were anti-HCV-antibody positive. Anti-HCV-antibody-positive patients spent a longer time on dialysis and had a higher rate of retransplantation. There were no differences in recipients' sex and age and donors' age between the two groups. The 7-year patient survival rate was 89.9% in the anti-HCV-antibody-positive group and 95.5% in the HCV-negative group (P = 0.74). Seven-year graft survival was 82.0% and 75.0% in the anti-HCV-antibody-positive and HCV-negative groups, respectively (P = 0.39). In the multivariate analysis, age was the only significant parameter correlated with patient survival (P = 0.02). CONCLUSIONS: HCV infection does not seem to influence patient and graft survival within a medium-time follow up in living allograft recipients, and anti-HCV-antibody positive status (alone) is not a contraindication for renal transplantation. However, further studies are needed to better define the role of HCV infection in long-term prognosis. 相似文献
22.
Ahmad Jameii Khosroshahi Ali Kianfar Behzad Mohammadpour Aharanjani Keyhan Sayadpour Zanjani 《Iranian journal of pediatrics.》2014,24(6):766-769
Objective:
We studied usefulness of serum B-type natriuretic peptide level as a screening tool for detecting hemodynamically significant patent ductus arteriosus in the preterm neonates.Methods:
Sixty admitted preterm neonates with gestational age ≤34 weeks, birth weight ≤2500 gr, and age of >3 days have been enrolled in this study. We measured serum B-type natriuretic peptide levels at the beginning and after completion of drug therapy for ductus occlusion.Findings:
Mean±SD gestational age and weight was 31±1.9 weeks and 1680±350 gr, respectively. The peptide levels in the neonates with significant duct (n=13) were significantly higher than in those with insignificant duct (n=17) or no duct (n=30) (1667±821 pg/ml versus 667±666 and 309±171, respectively). The peptide level dropped significantly after ibuprofen administration in the neonates with significant PDA (n=13), (1667±1165 pg/ml to 429±386).Conclusion:
At a cutoff point of 450 pg/ml, B-type natriuretic peptide level had a sensitivity of 92% and specificity of 87%, the negative predictive value of 98.5%, the positive likelihood ratio of 6.92 and the negative likelihood ratio of 0.089 for detecting significant patent duct. Levels below this can eliminate the need for echocardiography. 相似文献23.
Behzad Einollahi Alireza Ghadian Ebrahim Ghamar-Chehreh Seyed Moayed Alavian 《Hepatitis monthly》2014,14(2)
Background:
Liver enzymes elevations (LEE) can be observed after kidney transplantation due to multifactorial causes.Objectives:
We performed a retrospective study on 1589 kidney transplants, 971 male and 618 female, who were hepatitis B surface antigen (HBsAg) and hepatitis C virus-antibody (HCV Ab) negative, and had no other liver diseases, to detect the prevalence of LEE and its risk factors in these patients between May 2008 and May 2010.Patients and methods:
Liver enzymes and other biochemical parameters were measured in all recipients. Patients were divided into three groups, according to laboratory test time since transplantation: Group I, less than 3 months, Group II, 4 - 12 months after transplantation, and Group III, more than one year post-transplantation.Results:
The highest LEE was more frequent in older patients (P < 0.001) and male individuals (P < 0.001). Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were higher in patients who received kidneys from deceased donors (10.4% and 23.8%, respectively) as compared to living donor transplants (5.6% and 14.8%, respectively) (P < 0.001). The elevation of ALT was the liver enzyme abnormality after kidney transplantation with the highest prevalence (34.3%). The levels of ALT and AST were significantly elevated within the first 3 months after transplantation, followed by the 4-12 months period (P < 0.001). There was a reverse correlation between liver enzyme levels and renal allograft function in both univariate and linear regression analyses. This correlation increased over time. There was also a significant relation between cyclosporine blood levels and liver enzyme values in the univariate analysis. However, this relationship was attenuated over time. Elevated liver enzymes also correlated with anemia.Conclusions:
The LEE is a common finding among kidney transplant recipients. Serial monitoring of aminotransferases, particularly ALT, should be performed in all patients after kidney transplantation. 相似文献24.
Farahnaz Fahimipour Mina Mahdian Behzad Houshmand Mohammad Asnaashari Alireza Naser Sadrabadi Seid Emadadin Najafi Farashah Seid Mohsen Mousavifard Arash Khojasteh 《Lasers in medical science》2013,28(1):93-100
Low-level laser therapy (LLLT) has been used to accelerate wound healing, yet questions remain concerning its therapeutic applications. This study aimed to compare the healing efficacy of helium-neon (He-Ne) red light (laser) and gallium aluminum arsenide (Ga-Al-As) infrared lasers at two different doses on hard palate wounds. In a randomized controlled study, 75 adult male mice were divided into five groups of 15 each, after undergoing identical surgical procedures; a control group, with no laser irradiation; HD1 and HD2 groups, treated with He-Ne laser (wavelengths 632.8 nm, power 5 mW, and spot size 0.02 cm2) at doses of 4 J/cm2 and 7.5 J/cm2 respectively; and GD1 and GD2 groups, treated with Ga-Al-As laser (wavelengths 830 nm, peak power 25 mW, and spot size 0.10 cm2) at the doses of 4 J/cm2 and 7.5 J/cm2, respectively. Five animals from each group were killed on the third, seventh, and 14 days after surgery, and biopsies were made for histological analysis. On the 3rd and 7th day after the surgery, the number of polymorphonuclear cells (PMN) in HD1, HD2, GD1, and GD2 groups was significantly lower than that of the control group. On the 7th and 14th day, the fibroblasts and new blood vessels counts and collagen density fibers in HD1, HD2, GD1, and GD2 groups were also significantly higher than that of the control groups, and the fibroblast counts and collagen density fibers in HD1 and HD2 groups were higher than that of the GD1 and GD2 groups. LLLT with He-Ne laser compared to Ga-Al-As laser has a positive healing effect on hard palate gingival wounds in mice regardless of the radiation dose. 相似文献
25.
Malaria remains the most important parasitic infection in humans. There have been significant advances in the treatment of both nonsevere and severe malaria with the advent of artemisinin combination therapies and parenteral artesunate, but the optimum supportive management of severe malaria is unclear. A broadly acceptable therapy for the prevention of relapses in Plasmodium vivax infection has not been discovered. Globally, the priority remains to prevent infection in the vulnerable, to move toward elimination where feasible, and to ensure that effective treatment is available to all. In developed settings, prevention of infection and its early recognition are crucial. 相似文献
26.
27.
Mohan S Ahmed S Alimohammadi B Jaitly M Cheng JT Pogue VA 《The Journal of antimicrobial chemotherapy》2007,60(3):690-693
OBJECTIVES: Amphotericin B-induced nephrotoxicity is frequent, severe and associated with an increased risk of death. Patients with underlying renal disease are considered to be at high risk for amphotericin B nephrotoxicity. Amphotericin B is a molecule that is highly protein bound over a wide range of protein and drug concentrations, including those seen in patients with >or= 3 + proteinuria. We hypothesized that amphotericin B treatment in patients with proteinuria will be associated with less hypokalaemia than patients with non-proteinuric renal disease. METHODS: Thirty-six subjects who received amphotericin B deoxycholate were studied retrospectively. Twenty-five patients with proteinuria < 3 g/L and 11 with proteinuria >or= 3 g/L were compared. RESULTS: Hypokalaemia (K+ < 3.5 mmol/L) developed in 47.2% (17/36) of our cohort of patients. There was a 64% (16/25) incidence of hypokalaemia in the group with < 3 g/L of proteinuria in contrast to an incidence of 9.1% (1/11) in the other group. CONCLUSIONS: In our study, heavy proteinuria appears to protect the tubular luminal membrane by decreasing the luminal concentration of free drug available to bind with the membrane. Our findings redefine the patient population deemed to be at risk of developing amphotericin B nephrotoxicity. This ensures the benefit of this important antifungal treatment option to patients with heavy proteinuria who might otherwise not be administered this drug due to the presence of pre-existing kidney disease. 相似文献
28.
Gordon Jonathan S. Maynes Elizabeth J. O’Malley Thomas J. Pavri Behzad B. Tchantchaleishvili Vakhtang 《Journal of interventional cardiac electrophysiology》2021,61(1):1-10
Journal of Interventional Cardiac Electrophysiology - Many patients with continuous-flow left ventricular assist devices (CF-LVAD) have other, co-existing implantable cardiac devices. While such... 相似文献
29.
Mohammadrafie Khorgami Ali Sadeghpour Tabaei Elio Caruso Silvia Farruggio Negar Omidi Maryam Moradian Behzad Mohammadpour Ahranjani Zahra Khajali Rahele Zamani 《Congenital heart disease》2021,16(6):573-584
Background: Most children in need of cardiac pacemakers remain dependent on the function of the permanent
from childhood to adulthood. We sought to evaluate and compare the function between epicardial and endocardial
pacemakers in pediatric groups with different conditions. Methods: Between 2012 and 2018, this single-canter study
evaluated 44 pediatric patients with indications for epicardial or endocardial pacemakers. Results: The 2 groups, at a
median age of 5 (0.1–16) years, were compared concerning the characteristics of the leads used (n = 80: bipolar,
unipolar, steroid-eluting, and non–steroid-eluting), survival data, and complications. The reason for pacemaker
implantation was congenital complete heart block in 11 (25%) cases and postoperative heart block in 33 (75%) cases.
The commonest congenital heart disease accompanied by postoperative block was the ventricular septal defect. In
the endocardial lead group, the mean ventricular pacing threshold immediately after the implantation and during
the follow-up was less than that in the epicardial lead group (0.75 vs. 0.81 V; P = 0.01 and 0.8 vs. 2.4 V; P = 0.001).
During the follow-up, the mean battery longevity was better in the endocardial group (last visit: 6.7 endocardial vs.
3.3 years epicardial). Lead failure was commoner in the epicardial pacemaker, and chronic high-pacing threshold
pattern was seen in 14 patients in this group. After 3 years, freedom from lead failure was 94% and 63% in the
endocardial and epicardial leads. Conclusions: Pacemakers with endocardial bipolar steroid-eluting leads showed
better lead characteristics regarding survival and battery longevity than epicardial pacemakers without these lead
characteristics. An appropriate pacemaker type should be selected based on the patient’s condition. 相似文献
30.
Sinaei Niloufar Zare Mirakabadi Abbas Behnam Behzad Aminzadeh Azadeh Karami-Mohajeri Somayyeh 《Proceedings of the National Academy of Sciences, India. Section B.》2019,89(4):1161-1166
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - Despite advances in therapeutic strategies in the management of cancer, malignant glioma remains difficult to... 相似文献